Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Phillips

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
New Scientist (1971)|June 23, 2006
Who is messing with your head?Helen Phillips
New Scientist (1971)|May 7, 2003
Brain teaser: changing people's behaviour by implanting electrodes in their brains raises a host of troubling questionsHelen Phillips
New Scientist (1971)|May 7, 2003
Genes can come trueHelen Phillips
Orphanet Journal of Rare Diseases|June 22, 2018
Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial HypercholesterolaemiaDirk J Blom, Marina Cuchel, Miranda Ager, et al.
European Journal of Preventive Cardiology|September 20, 2017
The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysisRobert Leipold, Frederick Raal, Jack Ishak, et al.
Journal of Clinical Medicine|October 13, 2021
Diagnosing Autism Spectrum Disorders in Deaf Children Using Two Standardised Assessment Instruments: The ADIR-Deaf Adaptation and the ADOS-2 Deaf AdaptationVictoria Allgar, Barry Wright, Amelia Taylor, et al.
Communication & Medicine|February 7, 2025
Language brokering between deaf signing parents and healthcare professionalsAbigail Gee, Barry Wright, Jemina Napier, et al.
Metabolomics : Official Journal of the Metabolomic Society|August 2, 2022
Spectral binning as an approach to post-acquisition processing of high resolution FIE-MS metabolome fingerprinting dataJasen P Finch, Thomas Wilson, Laura Lyons, et al.
Journal of Clinical Lipidology|October 7, 2020
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)James A Underberg, Christopher P Cannon, Dominique Larrey, et al.
Orphanet Journal of Rare Diseases|July 11, 2024
Diagnosis, treatment and management of lipodystrophy: the physician perspective on the patient journeyNivedita Patni, Craig Chard, David Araújo-Vilar, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
New Scientist (1971)|June 23, 2006
Who is messing with your head?Helen Phillips
New Scientist (1971)|May 7, 2003
Brain teaser: changing people's behaviour by implanting electrodes in their brains raises a host of troubling questionsHelen Phillips
New Scientist (1971)|May 7, 2003
Genes can come trueHelen Phillips
Orphanet Journal of Rare Diseases|June 22, 2018
Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial HypercholesterolaemiaDirk J Blom, Marina Cuchel, Miranda Ager, et al.
European Journal of Preventive Cardiology|September 20, 2017
The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysisRobert Leipold, Frederick Raal, Jack Ishak, et al.
Journal of Clinical Medicine|October 13, 2021
Diagnosing Autism Spectrum Disorders in Deaf Children Using Two Standardised Assessment Instruments: The ADIR-Deaf Adaptation and the ADOS-2 Deaf AdaptationVictoria Allgar, Barry Wright, Amelia Taylor, et al.
Communication & Medicine|February 7, 2025
Language brokering between deaf signing parents and healthcare professionalsAbigail Gee, Barry Wright, Jemina Napier, et al.
Metabolomics : Official Journal of the Metabolomic Society|August 2, 2022
Spectral binning as an approach to post-acquisition processing of high resolution FIE-MS metabolome fingerprinting dataJasen P Finch, Thomas Wilson, Laura Lyons, et al.
Journal of Clinical Lipidology|October 7, 2020
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)James A Underberg, Christopher P Cannon, Dominique Larrey, et al.
Orphanet Journal of Rare Diseases|July 11, 2024
Diagnosis, treatment and management of lipodystrophy: the physician perspective on the patient journeyNivedita Patni, Craig Chard, David Araújo-Vilar, et al.
Pageof 3